Q4 2010

Filed Jun 14, 2011 · 10-K · 106 days after period end · 0001193805-11-001095

Q4 2010 · 10-K

derived · Computed from the longer spans the company filed.

Revenue—

Net income—

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Cash Flowderived-$11,000—

Same quarter

no prior Q4 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Feb 28, 2011 · filed Jun 14, 2011 · 106 d after period end

Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR